[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344958-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-344958-en":135},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","znf384-regulated-slc31a1-expression-promotes-tumor-proliferation-and-invasion-in-breast-cancer","ZNF384-regulated SLC31A1 expression promotes tumor proliferation and invasion in breast cancer","","Background SLC31A1, a copper transporter, is implicated in copper metabolism and may influence breast cancer progression. This study investigates SLC31A1’s function in breast cancer and explores regulatory mechanisms involving the transcription factor ZNF384. Methods leverage TCGA to compare SLC31A1 expression across cancer types and validate findings in an independent cohort of 80 paired breast tumor and adjacent normal tissues. Functional assays in MCF-7 and BT-549 cells assess proliferation, colony formation, and invasion after shRNA knockdown and overexpression. Results show higher SLC31A1 levels in tumors with poorer prognosis. ZNF384 regulates SLC31A1 through direct promoter binding confirmed by dual-luciferase reporter assays and ChIP. Conclusion SLC31A1 drives tumor proliferation and invasion and is regulated by ZNF384, suggesting copper-metabolism modulation as a potential therapeutic strategy and biomarker direction for breast cancer.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/znf384-regulated-slc31a1-expression-promotes-tumor-proliferation-and-invasion-in-breast-cancer/344958/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/znf384-regulated-slc31a1-expression-promotes-tumor-proliferation-and-invasion-in-breast-cancer/344958.png","ImageObject",300,407,{"name":42,"@type":43},"Aurora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is the primary role of SLC31A1 investigated in breast cancer?","Question",{"text":63,"@type":64},"The study focuses on SLC31A1’s function in breast cancer progression, including its impact on tumor cell proliferation and invasion.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was SLC31A1 expression analyzed and validated in this research?",{"text":68,"@type":64},"TCGA was used to analyze SLC31A1 expression across cancer types, and breast cancer tissue expression was validated in an independent cohort of 80 paired tumor and adjacent normal samples.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence supports that ZNF384 regulates SLC31A1?",{"text":72,"@type":64},"ZNF384 was identified by bioinformatics, and its direct binding to the SLC31A1 promoter was confirmed using dual-luciferase reporter assays and chromatin immunoprecipitation (ChIP).",{"name":74,"@type":61,"acceptedAnswer":75},"Why do the findings suggest a potential therapeutic strategy?",{"text":76,"@type":64},"Because SLC31A1 promotes proliferation and invasion and is controlled by ZNF384, targeting copper metabolism and its regulatory axis may offer novel approaches for breast cancer treatment.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},344958,1790676255,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,131],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":128,"slug":130},10,"Lifestyle","lifestyle",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":133,"show_sort_weight":101,"slug":134},19,"General","general",{"code":4,"msg":86,"data":136},{"doc_id":83,"user_id":137,"nickname":42,"user_avatar":138,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":144,"language":145,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":12,"update_tm":149,"read_time":150,"preview_page_count":33,"preview_urls":151},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","ZNF384-regulated SLC31A1 expression promotes tumor proliferation and invasion in breast cancer  \nTianzi Hong1,2 · Wenlian Li3 · Qingwei Wang2 · Zeyi Ye2 · Yueqin Xu2 · Bo Yang2 · Jiaxing Chen4 · Weibin Lian5 · Chuan Wang1  \nReceived: 9 July 2025 / Accepted: 16 December 2025 / Published online: 19 January 2026 © The Author(s) 2026  \nAbstract  \nBackground SLC31A1, a copper transporter, has been implicated in copper metabolism processes. This study aims to explore the function and potential regulatory mechanisms of SLC31A1 in breast cancer.  \nMethods The TCGA database was utilized to analyze SLC31A1 expression across various cancer types. SLC31A1 expression in breast cancer tissues was validated in an independent cohort of 80 paired breast cancer and adjacent normal tissues. SLC31A1 expression was manipulated in MCF-7 and BT-549 breast cancer cells using shRNA and overexpression vectors. Cell proliferation, colony formation, and invasion assays were performed to assess the functional consequences ofSLC31A1 manipulation. ZNF384, a potential transcription factor for SLC31A1, was identified through bioinformatics analysis, and its binding to the SLC31A1 promoter was confirmed using dual-luciferase reporter assays and chromatin immunoprecipitation (ChIP) .  \nResults SLC31A1 expression was significantly elevated in breast cancer tissues, and high expression was associated with poor prognosis. SLC31A1 promoted cell viability, colony formation, and invasion. ZNF384 was identified as a transcription factor that regulates SLC31A1 expression, and its overexpression enhanced SLC31A1 expression, while knockdown of ZNF384 inhibited breast cancer cell proliferation and invasion. ChIP assays confirmed a direct interaction between ZNF384 and the SLC31A1 promoter.  \nConclusion SLC31A1 plays a crucial role in the proliferation and invasion of breast cancer cells, and its expression is regulated by ZNF384 . These findings highlight SLC31A1 as a potential therapeutic target and suggest that modulation of copper metabolism may offer novel strategies for breast cancer treatment.  \nKeywords SLC31A1 · Breast cancer · ZNF384 · Copper metabolism · Cell proliferation · Invasion · Biomarkers  \nTianzi Hong and Wenlian Li contributed equally to this work.  \n􀀍 Weibin Lian [weibinlian@fjmu.edu.cn](weibinlian@fjmu.edu.cn)  \n􀀍 Chuan Wang [dr_chuanwang@fjmu.edu.cn](dr_chuanwang@fjmu.edu.cn)  \n1 Department of Breast Surgery, Fujian Medical University Union Hospital, No.29, Xinquan Road, Gulou District, Fuzhou 350000, Fujian, P.R. China  \n2 Department of Thyroid and Breast Surgery, Jinjiang Municipal Hospital (Shanghai Sixth People’s Hospital Fujian), Quanzhou 362000, Fujian, P.R. China  \n3 Department of Breast Surgery, Zhongshan Hospital of Xiamen University, Xiamen 361000, Fujian, P.R. China  \n4 Department of Pathology, Jinjiang Municipal Hospital (Shanghai Sixth People’s Hospital Fujian), Quanzhou 362000, Fujian, P.R. China  \n5 Department of Breast Surgery, Quanzhou First Hospital Affiliated to Fujian Medical University, No. 248-252 East Street, Licheng District, Quanzhou 362000, Fujian, P.R. China  \nIntroduction  \nCancer remains a significant global health challenge, with breast cancer being one of the most prevalent forms. Understanding the key aspects of cancer biology and the evolution of treatment strategies is crucial for advancing therapeutic approaches. At present, breast cancer is the fourth cancer in terms of mortality. In the statistics of 2022, breast cancer is the second cancer in terms of the number of new cases [1] . The cure rate of breast cancer has improved in the past decades, especially with the progress of early diagnosis and targeted treatment, the five-year survival rate has reached more than 90% in many countries [2, 3] . Cancer therapy has evolved from conventional modalities—such as surgery, radiotherapy, and chemotherapy—toward more precise approaches, including targeted therapy and immunotherapy. The field has transitioned from non-spe","cbCaidNS0fxscfQX","https://ap.wps.com/l/cbCaidNS0fxscfQX","pdf",9643808,15,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Breast cancer as a global health challenge\n## Evolution of therapies and tumor microenvironment\n## Biomarkers and precision medicine\n## Cuproptosis and copper metabolism in cancer","[{\"question\":\"What is the primary role of SLC31A1 investigated in breast cancer?\",\"answer\":\"The study focuses on SLC31A1’s function in breast cancer progression, including its impact on tumor cell proliferation and invasion.\"},{\"question\":\"How was SLC31A1 expression analyzed and validated in this research?\",\"answer\":\"TCGA was used to analyze SLC31A1 expression across cancer types, and breast cancer tissue expression was validated in an independent cohort of 80 paired tumor and adjacent normal samples.\"},{\"question\":\"What evidence supports that ZNF384 regulates SLC31A1?\",\"answer\":\"ZNF384 was identified by bioinformatics, and its direct binding to the SLC31A1 promoter was confirmed using dual-luciferase reporter assays and chromatin immunoprecipitation (ChIP).\"},{\"question\":\"Why do the findings suggest a potential therapeutic strategy?\",\"answer\":\"Because SLC31A1 promotes proliferation and invasion and is controlled by ZNF384, targeting copper metabolism and its regulatory axis may offer novel approaches for breast cancer treatment.\"}]","ZNF384-regulated SLC31A1 expression promotes tumor proliferation and invasion in breast cancer | PDF",1790055960,38,[152,156,160,164],{"page_no":22,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ceabe42a36f0b800d04897fa39bcff5b.webp",983,1305,{"page_no":26,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53ddcda71074ddcb02dd763b420e334c.webp",982,1304,{"page_no":30,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/381195da88ab56617ebdfc995360ce72.webp",981,1303,{"page_no":33,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea663ab2999c79dda765a3288fb7a497.webp",980,1301]